These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8318645)

  • 21. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis.
    Harvey JM; Sterrett GF; Frost FA
    Pathology; 2002 Oct; 34(5):410-6. PubMed ID: 12408338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence of obscure carcinoma in subcutaneous mastectomy. Results of a national survey.
    Pennisi VR; Capozzi A
    Plast Reconstr Surg; 1975 Jul; 56(1):9-12. PubMed ID: 1144551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer risk assessment in benign breast biopsies.
    Page DL
    Hum Pathol; 1986 Sep; 17(9):871-4. PubMed ID: 3759071
    [No Abstract]   [Full Text] [Related]  

  • 24. [Atypical ductal and lobular hyperplasia of the breast].
    Bricou A; Delpech Y; Barranger E
    Gynecol Obstet Fertil; 2009 Oct; 37(10):814-9. PubMed ID: 19766043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mastopathy. Histological forms and long-term observations].
    Prechtel K
    Zentralbl Pathol; 1991; 137(3):210-9. PubMed ID: 1931894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The patho-epidemiology of benign proliferative epithelial disorders of the female breast.
    Cook MG; Rohan TE
    J Pathol; 1985 May; 146(1):1-15. PubMed ID: 3891937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of precancerous conditions of the breast].
    Piana L; Seradour B; Bonneau HP; Serment H
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):106-7. PubMed ID: 7451849
    [No Abstract]   [Full Text] [Related]  

  • 28. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.
    Hoogerbrugge N; Bult P; de Widt-Levert LM; Beex LV; Kiemeney LA; Ligtenberg MJ; Massuger LF; Boetes C; Manders P; Brunner HG
    J Clin Oncol; 2003 Jan; 21(1):41-5. PubMed ID: 12506168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cancer of the breast. I. Epidemiology and risk factors (our experience)].
    Macellari G; Giarelli C
    Minerva Chir; 1989 Jun; 44(12):1655-8. PubMed ID: 2771117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The woman at high risk for breast cancer. Importance of hyperplasia.
    Page DL
    Surg Clin North Am; 1996 Apr; 76(2):221-30. PubMed ID: 8610260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The transition from hyperplasia to invasive carcinoma of the breast.
    Lakhani SR
    J Pathol; 1999 Feb; 187(3):272-8. PubMed ID: 10398078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiology of dyshormonal diseases and malignant tumors of the breast].
    Ismaĭlov AKh
    Khirurgiia (Mosk); 1986 Sep; (9):31-3. PubMed ID: 3795806
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of breast cancer, descriptive and analytical review.
    Mostafa MS
    J Egypt Public Health Assoc; 1990; 65(1-2):11-36. PubMed ID: 2133701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anatomic markers of human mammary premalignancy and incipient breast cancer.
    Page DL
    Recent Results Cancer Res; 1988; 106():65-72. PubMed ID: 3285417
    [No Abstract]   [Full Text] [Related]  

  • 36. [Problems of hypo- and hyperdiagnosis of breast cancer].
    Ismaĭlov AKh
    Khirurgiia (Mosk); 1983 Nov; (11):47-8. PubMed ID: 6664009
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast.
    Tavassoli FA; Norris HJ
    Cancer; 1990 Feb; 65(3):518-29. PubMed ID: 2297643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphology of the premalignant lesions of the breast.
    Saksela E
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():11-6. PubMed ID: 8298439
    [No Abstract]   [Full Text] [Related]  

  • 39. [Node status in 454 ductal breast cancers cases according to the association with in situ component].
    Carabias-Meseguer P; Cusidó-Gimferrer M; Zapardiel-Gutiérrez I; Tresserra-Casas F; Fábregas-Xauradó R; Xercavins-Montoya J
    Ginecol Obstet Mex; 2011 Jan; 79(1):5-10. PubMed ID: 21966777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Premalignant conditions and markers of elevated risk in the breast and their management.
    Page DL; Dupont WD
    Surg Clin North Am; 1990 Aug; 70(4):831-51. PubMed ID: 2371647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.